Medications

Unituxin approved for deadly pediatric cancer

(HealthDay)—Unituxin (dinutuximab) has been approved by the U.S. Food and Drug Administration to treat children with high-risk neuroblastoma, a rare cancer that most often affects children aged five and under.

Oncology & Cancer

Lenvima approved for common thyroid cancer

(HealthDay)—Lenvima (lenvatinib) has been approved by the U.S. Food and Drug Administration to treat differentiated thyroid cancer (DTC) that has progressed despite radioactive iodine therapy, the agency said Friday in ...

Health

Many seniors not reporting falls to physician

(HealthDay)—Millions of Americans aged 65 and older fall every year, according to the U.S. Centers for Disease Control and Prevention. But, fewer than half tell their doctor, according to a news release issued by the Penn ...

page 35 from 40